Basler Kantonalbank Stock

Certificat

BBYBKB

CH1225283022

Market Closed - Swiss Exchange 11:20:00 2024-06-05 EDT
89.55 CHF +0.07% Intraday chart for Basler Kantonalbank
Current month+4.54%
1 month+10.46%
Date Price Change
24-06-05 89.55 +0.07%
24-06-04 89.49 +0.10%
24-06-03 89.4 +4.37%
24-05-31 85.66 +2.61%
24-05-29 83.48 -2.64%

Delayed Quote Swiss Exchange

Last update June 05, 2024 at 11:20 am

More quotes

Static data

Product typeObligations Convertibles
Buy / SellCALL
Underlying MERCK KGAA
Issuer Basler Kantonalbank
BBYBKB
ISINCH1225283022
Date issued 2023-01-30
Strike 193.6
Maturity 2025-01-30 (238 Days)
Parity 1 : 1
Emission price 99.54 CHF
Emission volume N/A
Settlement les deux
Currency CHF

Technical Indicators

Highest since issue 100.4 CHF
Lowest since issue 69.9 CHF
Spread 8 CHF
Spread %0.89%

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
171.9 EUR
Average target price
186.1 EUR
Spread / Average Target
+8.24%
Consensus
  1. Stock Market
  2. Certificates
  3. BBYBKB Certificat